首页|CRRT与IHD对急性肾衰竭病人免疫功能与血流动力学及预后的影响

CRRT与IHD对急性肾衰竭病人免疫功能与血流动力学及预后的影响

扫码查看
目的 对比研究连续肾脏替代疗法(CRRT)与间歇性血液透析疗法(IHD)治疗急性肾衰竭(ARF)的临床预后及对病人免疫功能、血流动力学的影响.方法 采用前瞻性研究方法,选择我院2014年1月-2017年1月收治的ARF病人140例,按随机数字表法分为CRRT组68例和IHD组72例,两组分别采用CRRT和IHD治疗.比较两组病人治疗前后的电解质、pH值、肾功能指标、免疫功能指标、血流动力学参数及临床预后.结果 治疗结束6h时,CRRT组病人的心率、平均动脉压、体循环阻力、肺血管阻力均显著优于IHD组(t=2.496~13.091,P<0.05).治疗7d时,CRRT组病人的血肌酐、尿素氮、K+显著低于IHD组(t=9.957~14.534,P<0.05),Na+、HCO3-及pH值显著高于IHD组(t=4.488~11.791,P<0.05).治疗7d时,CRRT组病人的CD4+、CD4+/CD8+、IgA、IgG均显著高于IHD组,CD8+显著低于IHD组(t=8.589~19.425,P<0.05).治疗7d时,CRRT组病人的APACHEⅡ评分显著低于IHD组(t=8.447,P<0.05),尿量恢复时间、器官支持时间、住ICU时间均较IHD组明显缩短(t=5.415~7.611,P<0.05).CRRT组病人心血管事件总发生率为13.24%,显著低于IHD组的33.33%(x2=7.841,P<0.05).两组治疗7d时的生存率差异无统计学意义(P>0.05),但CRRT组病人治疗15、30 d时的生存率显著高于IHD组(x2=4.503、4.498,P<0.05),且治疗7、15、30 d时的肾功能恢复率均显著高于IHD组(x2 =4.203~6.460,P<0.05).结论 CRRT与IHD治疗ARF均具有良好效果,但CRRT能够更好地维持内环境及血流动力学稳定、增强免疫功能,对心血管影响更小,从而改善临床预后.
EFFECTS OF CRRT AND IHD ON IMMUNE FUNCTION, HEMODYNAMICS, AND PROGNOSIS IN PATIENTS WITH ACUTE RENAL FAILURE
Objective To investigate the effects of continuous renal replacement therapy (CRRT) and intermittent hemodialysis (IHD) on immune function,hemodynamics,and prognosis in patients with acute renal failure (ARF).Methods A prospective study was performed in 140 patients with ARF who were admitted to our hospital from January 2014 to January 2017.They were randomly divided into two groups using a random number table:CRRT group (n =68) and IHD group (n =72).The two groups were treated with CRRT and IHD,respectively.The following indices before and after treatment were compared be tween the two groups:electrolyte,pH,renal function parameters,immune function parameters,hemodynamic parameters,and clinical outcomes.Results At 6 hours after treatment,the CRRT group had significantly better heart rate,mean arterial pressure,systemic vascular resistance,and pulmonary vascular resistance than the IHD group (t =2.496-13.091,P<0.05).On day 7 of treatment,compared with the IHD group,the CRRT group had significantly lower levels of serum creatinine,blood urea nitrogen,and K+ (t=9.957-14.534,P<0.05) and significantly higher levels of Na+ and HCO3-and pH (t =4.488-11.791,P<0.05),as well as significantly higher percentage of CD4+ T cells,CD4+/CD8+ ratio,and levels of IgA and IgG,and a significantly lower percentage of CD8+ T cells (t =8.589-19.425,P <0.05);in addition,the CRRT group had a significantly lower APACHE Ⅱ score and significantly shorter time to recovery of urine output,organ support time,and length of ICU stay than the IHD group (t =5.415-8.447,P <0.05).The CRRT group had a significantly lower overall incidence rate of cardiovascular events than the IHD group (13.24 % vs 33.33 %,x2 =7.841,P<0.05).There was no significant difference in survival rate on day 7 of treatment between the two groups (P>0.05).However,the CRRT group had significantly higher survival rates on days 15 and 30 of treatment (x2=4.503,4.498;P<0.05) and recovery rates of renal function on days 7,15,and 30 of treatment (x2=4.203-6.460,P<0.05) compared with the IHD group.Conclusion CRRT and IHD have good efficacy in the treatment of ARF.However,compared with IHD,CRRT can more effectively maintain the stability of the internal environment and hemodynamics and enhance immune function and has fewer effects on the cardiovascular system,so as to improve the clinical outcome of ARF.

acute kidney injuryrenal replacement therapyrenal dialysisimmune functionhemodynamicsprognosis

李丽、薛婷、卓越

展开 >

徐州医科大学附属医院急诊ICU,江苏徐州 221000

急性肾损伤 肾替代疗法 肾透析 免疫功能 血流动力学 预后

2017

齐鲁医学杂志
青岛大学医学院

齐鲁医学杂志

影响因子:0.609
ISSN:1008-0341
年,卷(期):2017.32(5)
  • 7
  • 15